BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 11803092)

  • 1. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review.
    Alfirevic Z; Roberts D; Martlew V
    Eur J Obstet Gynecol Reprod Biol; 2002 Feb; 101(1):6-14. PubMed ID: 11803092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherited and acquired thrombophilia: pregnancy outcome and treatment.
    De Santis M; Cavaliere AF; Straface G; Di Gianantonio E; Caruso A
    Reprod Toxicol; 2006 Aug; 22(2):227-33. PubMed ID: 16797917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and management of inherited thrombophilias in the setting of adverse pregnancy outcome.
    Paidas MJ; Ku DH; Arkel YS
    Clin Perinatol; 2004 Dec; 31(4):783-805, vii. PubMed ID: 15519428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inherited thrombophilias and adverse pregnancy outcomes: a case-control study in an Australian population.
    Said JM; Higgins JR; Moses EK; Walker SP; Monagle PT; Brennecke SP
    Acta Obstet Gynecol Scand; 2012 Feb; 91(2):250-5. PubMed ID: 21985600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?
    Mousa HA; Alfirevic1 Z
    Hum Reprod; 2000 Aug; 15(8):1830-3. PubMed ID: 10920112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. -455G/A beta-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications.
    Camilleri RS; Peebles D; Portmann C; Everington T; Cohen H
    Blood Coagul Fibrinolysis; 2004 Mar; 15(2):139-47. PubMed ID: 15091001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postnatal screening for thrombophilia in women with severe pregnancy complications.
    Alfirevic Z; Mousa HA; Martlew V; Briscoe L; Perez-Casal M; Toh CH
    Obstet Gynecol; 2001 May; 97(5 Pt 1):753-9. PubMed ID: 11339929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased frequency of genetic thrombophilia in women with complications of pregnancy.
    Kupferminc MJ; Eldor A; Steinman N; Many A; Bar-Am A; Jaffa A; Fait G; Lessing JB
    N Engl J Med; 1999 Jan; 340(1):9-13. PubMed ID: 9878639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single inherited thrombophilias and adverse pregnancy outcomes.
    Larciprete G; Gioia S; Angelucci PA; Brosio F; Barbati G; Angelucci GP; Frigo MG; Baiocco F; Romanini ME; Arduini D; Cirese E
    J Obstet Gynaecol Res; 2007 Aug; 33(4):423-30. PubMed ID: 17688607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome.
    Agorastos T; Karavida A; Lambropoulos A; Constantinidis T; Tzitzimikas S; Chrisafi S; Saravelos H; Vavilis D; Kotsis A; Bontis J
    J Matern Fetal Neonatal Med; 2002 Oct; 12(4):267-73. PubMed ID: 12572596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripartum thromboprophylaxis for homozygous and heterozygous FVL mutation carriers yields similar pregnancy outcome.
    Gat I; Dulitzki M; Schiff E; Sivan E; Simchen MJ
    Isr Med Assoc J; 2014 Feb; 16(2):96-100. PubMed ID: 24645228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of inherited thrombophilia on the development of some pregnancy complications].
    Koleva R; Dimitrova V; Chernev T; Savov A; Karag'ozova Zh; Mazneŭkova V; Kremenski I
    Akush Ginekol (Sofiia); 2005; 44(5):18-26. PubMed ID: 16313049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placenta-mediated pregnancy complications are not associated with fetal or paternal factor V Leiden mutation.
    Nevalainen J; Ignatius J; Savolainen ER; Ryynanen M; Jarvenpaa J
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():32-35. PubMed ID: 30243226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombophilia in pregnancy.
    Tan JY
    Ann Acad Med Singap; 2002 May; 31(3):328-34. PubMed ID: 12061293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal thrombophilias are not associated with early pregnancy loss.
    Roqué H; Paidas MJ; Funai EF; Kuczynski E; Lockwood CJ
    Thromb Haemost; 2004 Feb; 91(2):290-5. PubMed ID: 14961156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombophilia and adverse pregnancy outcome.
    Brenner B
    Obstet Gynecol Clin North Am; 2006 Sep; 33(3):443-56, ix. PubMed ID: 16962920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombophilia and adverse maternal-perinatal outcome: controversies in screening and management.
    Stella CL; How HY; Sibai BM
    Am J Perinatol; 2006 Nov; 23(8):499-506. PubMed ID: 17094039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women.
    Said JM; Higgins JR; Moses EK; Walker SP; Borg AJ; Monagle PT; Brennecke SP
    Obstet Gynecol; 2010 Jan; 115(1):5-13. PubMed ID: 20027027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
    Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
    Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombophilia, preeclampsia and other pregnancy complications].
    Vucić N; Frleta M; Petrović D; Ostojić V
    Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.